Glancy Binkow & Goldberg LLP announces that it is investigating potential claims against the Board of Directors of Cost Plus, Inc. (“Cost Plus” or the “Company”) CPWM related to the proposed acquisition of the Company by Bed Bath & Beyond. The transaction is valued at approximately $495 million or $22 per share.
This investigation concerns whether the Board of Directors of Cost Plus breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the proposed transaction, and whether the Company has disclosed all material information to shareholders about the transaction. The Company has seen substantial recent growth. Its share price has skyrocketed from $5.60 on October 3, 2011 to $19.84 on April 27, 2012.
If you are a shareholder of Cost Plus, if you have information or would like to learn more about our investigation, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Louis Boyarsky, Esquire, Glancy Binkow & Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles, CA 90067, by telephone at (310) 201-9150 or Toll Free at (888) 773-9224 or by email to shareholders@glancylaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Glancy Binkow & Goldberg LLP
Louis Boyarsky, Esquire
310-201-9150
or Toll Free: 888-773-9224
shareholders@glancylaw.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.